EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

RNA Regulatory Networks: Key Hubs in the Panorama of Cancer and Emerging Therapeutic Targets

Xuan Yin, Zengkan Du, Shuya Jiang, Yan Liao, Changli Wang, Jiaqi Li, Haoling Zhang, Ting-Ting Wei, Wangzheqi Zhang, Zui Zou iD

MedComm · 2026-03 · 7 (3)

DOI: 10.1002/mco2.70586 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 24.02.2026. Verfasst von Xuan Yin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Anesthesiology, Changhai Hospital Naval Medical University Shanghai China. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 684 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer is a global health challenge. The initiation and progression of cancer are correlated with dynamic dysregulation of RNA regulatory networks. This review systematically explains how contending RNAs (including mRNA, miRNA, lncRNA, circRNA, etc.) remold gene expression programs across multiple dimensions. They do this primarily through the competing endogenous RNA sponge effect, RNA–protein complex assembly, RNA editing (A‐to‐I editing, m6A modification, etc.), tumorigenesis, heterogeneous evolution, and therapeutic resistance. RNA regulatory networks do not only help one to decode cancer biology but because they are dynamic in nature, they are now also being looked at as good precision targets for diagnosis and treatment. This article integrates recent findings on the emerging functions of RNA networks in tumor metabolic reprogramming, tumor immune microenvironment shaping, and cancer stem cell property maintenance, while highlighting their clinical application prospects as liquid biopsy biomarkers. Our therapies focus on assessing the potential and clinical translation bottlenecks of novel RNA‐targeted interventions, including antisense oligonucleotides, RNA aptamers, and the CRISPR–Cas13 system. A dynamic adjustability made the RNA‐targeted therapies promising intervention nodes in precision medicine even if most of them are still in a preclinical state.

Schlagwörter

Stichwörter der Autor:innen

RNA regulatory networkcancerliquid biopsyprecision medicinetherapeutic target

Autor:innen und Institutionen

  • Faculty of Anesthesiology, Changhai Hospital Naval Medical University Shanghai China.
  • Basic Medical University Naval Medical University Shanghai China.
  • Department of Gastroenterology, National Clinical Research Center For Digestive Diseases, Changhai Hospital Naval Medical University Shanghai China.
  • The Third Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital Naval Medical University Shanghai China.
  • School of Anesthesiology Naval Medical University Shanghai China.
  • Department of Biomedical Science Universiti Sains Malaysia Penang Malaysia.

ORCID-Profile: Zui Zou

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Yin, X., Du, Z., Jiang, S., Liao, Y., Wang, C., Li, J., Zhang, H., Wei, T. T., Zhang, W., & Zou, Z. (2026). RNA Regulatory Networks: Key Hubs in the Panorama of Cancer and Emerging Therapeutic Targets. MedComm, 7(3). https://doi.org/10.1002/mco2.70586

Vancouver

Yin X, Du Z, Jiang S, Liao Y, Wang C, Li J, et al. RNA Regulatory Networks: Key Hubs in the Panorama of Cancer and Emerging Therapeutic Targets. MedComm. 2026;7(3). doi:10.1002/mco2.70586

BibTeX
@article{Yin2026,
  author = {Yin, Xuan and Du, Zengkan and Jiang, Shuya and Liao, Yan and Wang, Changli and Li, Jiaqi and Zhang, Haoling and Wei, Ting-Ting and Zhang, Wangzheqi and Zou, Zui},
  title = {RNA Regulatory Networks: Key Hubs in the Panorama of Cancer and Emerging Therapeutic Targets},
  journal = {MedComm},
  year = {2026},
  volume = {7},
  number = {3},
  doi = {10.1002/mco2.70586}
}
Kostenlos starten →